Blog
No posts found.
-
Customers success stories
Hybridoma-based antibody development: Targeting Key Protein in Long QT Syndrome and Advancing Cardiac Research
Read more -
Others
An International presence, local service
Read more -
CAR-T cell therapy
From the first to the fifth generation of CAR-T cells
Read more -
Antibody production
Budget Busters: How to Manage Costs and Resources in Antibody Development
Read more -
CAR-T cell therapy
The structure of CAR-T cells
Read more
-
Others
An International presence, local service
Read more -
Customers success stories
Hybridoma-based antibody development: Targeting Key Protein in Long QT Syndrome and Advancing Cardiac Research
Read more -
Others
Key events of 2025: Meet us to discuss innovation!
Read more -
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Read more -
Customers success stories
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Read more -
Antibody production
Reinventing IgY biotherapeutics
Read more -
Antibody production
How the environment shapes immune system development during pregnancy
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Read more